Arvinas reported early-stage data for its PROTAC program in healthy volunteers, hoping the results will eventually translate ...
F-star Therapeutics becomes private, independent company after separating from invoX, plans to continue bispecific antibody ...
The Senate on Thursday voted to confirm trained surgeon and former daytime TV host Mehmet Oz as the next CMS administrator, ...
Roche on Thursday shared early positive results for its Alzheimer’s candidate trontinemab, the latest round of data in its ...
Drugmakers have leverage and are getting 'a real negotiation' with the government over the prices of products selected under ...
HHS Secretary Robert F. Kennedy Jr. has been called to testify before the Senate HELP and House E&C Committees following ...
President Donald Trump on Wednesday announced broad 10% global tariffs in a move that pharma industry groups worry will upend ...
FDA rejects Aldeyra's dry eye drug reproxalap again, seeks more data. Company plans 2025 resubmission. AbbVie partnership ...
SHL Medical opens $220M SC factory, DHL acquires Cryopdp, AGC forms new division, new facilities for NBE, Siemens-Miko Ghana ...
There were nine PIPEs in the first quarter of 2025, compared to 34 in the same quarter of last year, according to data shared ...
MoonLake Immunotherapeutics gets $75M upfront from Hercules Capital in $500M financing deal; OSR Holdings to sell $80M in ...
Daymark Health launches with $11.5M from investors including Maverick Ventures and Yosemite to provide comprehensive care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results